128 related articles for article (PubMed ID: 22541091)
1. [Predictive value of tissue factor-associated platelet microparticles in thrombosis of patients with lymphoma].
Tang YL; Zhou Y; Wang CB; Qin Y; Feng J; Qin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):325-8. PubMed ID: 22541091
[TBL] [Abstract][Full Text] [Related]
2. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
[TBL] [Abstract][Full Text] [Related]
4. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
Suades R; Padró T; Vilahur G; Badimon L
Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
[TBL] [Abstract][Full Text] [Related]
5.
Nijiati M; Saidaming A; Guoqing L
Ann Clin Lab Sci; 2017 Mar; 47(2):156-161. PubMed ID: 28442516
[TBL] [Abstract][Full Text] [Related]
6. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis.
Ye R; Ye C; Huang Y; Liu L; Wang S
Thromb Res; 2012 Aug; 130(2):253-8. PubMed ID: 22099707
[TBL] [Abstract][Full Text] [Related]
7. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
[TBL] [Abstract][Full Text] [Related]
8. Platelet microparticles in cryopreserved platelets: Potential mediators of haemostasis.
Johnson L; Raynel S; Seghatchian J; Marks DC
Transfus Apher Sci; 2015 Oct; 53(2):146-52. PubMed ID: 26549672
[TBL] [Abstract][Full Text] [Related]
9. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
[TBL] [Abstract][Full Text] [Related]
10. Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden.
Lincz LF; Scorgie FE; Enjeti A; Seldon M
Thromb Res; 2012 Feb; 129(2):192-6. PubMed ID: 21798575
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis, platelets, microparticles and PAH: more than a clot.
Lannan KL; Phipps RP; White RJ
Drug Discov Today; 2014 Aug; 19(8):1230-5. PubMed ID: 24747560
[TBL] [Abstract][Full Text] [Related]
13. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
Suades R; Padró T; Alonso R; Mata P; Badimon L
Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients.
Tilley RE; Holscher T; Belani R; Nieva J; Mackman N
Thromb Res; 2008; 122(5):604-9. PubMed ID: 18262600
[TBL] [Abstract][Full Text] [Related]
15. Microvesicles as risk markers for venous thrombosis.
Rautou PE; Mackman N
Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784
[TBL] [Abstract][Full Text] [Related]
16. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets.
Chen YW; Chen JK; Wang JS
Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321
[TBL] [Abstract][Full Text] [Related]
17. Involvement of platelet-derived microparticles in tumor progression and thrombosis.
Mezouar S; Mege D; Darbousset R; Farge D; Debourdeau P; Dignat-George F; Panicot-Dubois L; Dubois C
Semin Oncol; 2014 Jun; 41(3):346-58. PubMed ID: 25023350
[TBL] [Abstract][Full Text] [Related]
18. Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction.
Del Turco S; Basta G; Lazzerini G; Evangelista M; Rainaldi G; Tanganelli P; Christensen JH; Schmidt EB; De Caterina R
Haematologica; 2008 Jun; 93(6):892-9. PubMed ID: 18469350
[TBL] [Abstract][Full Text] [Related]
19. Analysis of apoptotic, platelet-derived, endothelial-derived, and tissue factor-positive microparticles of children with acute lymphoblastic leukemia during induction therapy.
Yenigürbüz FD; Kızmazoğlu D; Ateş H; Erdem M; Tüfekçi Ö; Yılmaz Ş; Ören H
Blood Coagul Fibrinolysis; 2019 Jun; 30(4):149-155. PubMed ID: 31090597
[TBL] [Abstract][Full Text] [Related]
20. Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation?
Jesel L; Arentz T; Herrera-Siklody C; Trenk D; Zobairi F; Abbas M; Weber R; Minners J; Toti F; Morel O
J Cardiovasc Electrophysiol; 2014 Mar; 25(3):266-70. PubMed ID: 24172190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
